ВИНКРИСТИНОВАЯ НЕЙРОПАТИЯ
Основное содержимое статьи
Аннотация
Информация о статье
Раздел

Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Как цитировать
Библиографические ссылки
Verstappen, C. C. P., Heimans, J. J., Hoekman, K., Postma, T. J. (2003). Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs, 63(15), 1549–1563.
Cavaletti, G., Marmiroli, P. (2010). Chemotherapy-induced peripheral neurotoxicity. Current Opinion in Neurology, 23(5), 566–575.
Gomber, S., Dewan, P., Chhonker, D. (2010). Vincristine induced neurotoxicity: Diagnosis and management. Indian Journal of Pediatrics, 77(6), 643–646.
Park, S. B., Goldstein, D., Krishnan, A. V., Lin, C. S. Y., Friedlander, M. L., Kiernan, M. C. (2013). Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA: A Cancer Journal for Clinicians, 63(6), 419–437.
Verstappen, C. C. P., Postma, T. J., Hoekman, K., Heimans, J. J. (2005). Peripheral neuropathy due to chemotherapy: A review on the pathophysiology and therapeutic options. European Journal of Cancer, 41(3), 437–445.
Starobova, H., Vetter, I. (2017). Pathophysiology of chemotherapy-induced peripheral neuropathy. Frontiers in Molecular Neuroscience, 10, 174.
Windebank, A. J., Grisold, W. (2008). Chemotherapy-induced neuropathy. Journal of the Peripheral Nervous System, 13(1), 27–46.
Grisold, W., Cavaletti, G., Windebank, A. J. (2012). Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro-Oncology, 14(suppl_4), iv45–iv54.